Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon
Babatunde Adedokun et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Olga Martinez-Saez et al.
BREAST CANCER RESEARCH (2020)
Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer
Xinyi Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance
Nishant Batta et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Timothy R. Rebbeck et al.
HUMAN MUTATION (2018)
Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls
Yukihide Momozawa et al.
NATURE COMMUNICATIONS (2018)
BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso
Abdou Azaque Zoure et al.
JOURNAL OF PUBLIC HEALTH IN AFRICA (2018)
Genetics of breast cancer in African populations: a literature review
A. Abbad et al.
GLOBAL HEALTH EPIDEMIOLOGY AND GENOMICS (2018)
Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2
Cornelia Kraus et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
COSMIC: somatic cancer genetics at high-resolution
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2017)
Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing
Guoli Li et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
PARP inhibitors: Synthetic lethality in the clinic
Christopher J. Lord et al.
SCIENCE (2017)
Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
C. Winter et al.
ANNALS OF ONCOLOGY (2016)
TP53 Codon 72 Polymorphism Predicts Efficacy of Paclitaxel Plus Capecitabine Chemotherapy in Advanced Gastric Cancer Patients
Yong Zha et al.
ARCHIVES OF MEDICAL RESEARCH (2016)
Molecular evaluation of PIK3CA gene mutation in breast cancer: determination of frequency, distribution pattern and its association with clinicopathological findings in Indian patients
Firoz Ahmad et al.
MEDICAL ONCOLOGY (2016)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal et al.
NATURE (2016)
Mutation of genes of the PI3K/AKT pathway in breast cancer supports their potential importance as biomarker for breast cancer aggressiveness
Aggeliki Tserga et al.
VIRCHOWS ARCHIV (2016)
Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors
Sherri Z. Millis et al.
JAMA ONCOLOGY (2016)
BRCA1, BRCA2 and PALB2 mutations and CHEK2 c. 1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer
F. Z. Francies et al.
BMC CANCER (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru
J. Abugattas et al.
CLINICAL GENETICS (2015)
Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia
A. Riahi et al.
CLINICAL GENETICS (2015)
Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing
Suqin Liu et al.
HUMAN GENOMICS (2015)
From the set-up of a screening program of breast cancer patients to the identification of the first BRCA mutation in the DR Congo
Gertrude Luyeye Mvila et al.
BMC PUBLIC HEALTH (2014)
Prospective Enterprise-Level Molecular Genotyping of a Cohort of Cancer Patients
Laura E. MacConaill et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
PIK3CA and TP53 Gene Mutations in Human Breast Cancer Tumors Frequently Detected by Ion Torrent DNA Sequencing
Xusheng Bai et al.
PLOS ONE (2014)
Analysis of PIK3CA Mutations in Breast Cancer Subtypes
Ruza Arsenic et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2014)
Germline PIK3CA and AKT1 Mutations in Cowden and Cowden-like Syndromes
Mohammed S. Orloff et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling
S. Richter et al.
ANNALS OF ONCOLOGY (2013)
Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes
Sandrine Boyault et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients
James D. Fackenthal et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Novel BRCA1 deleterious mutation (c.1949_1950delTA) in a woman of Senegalese descent with triple-negative early-onset breast cancer
Orland Diez et al.
ONCOLOGY LETTERS (2011)
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece
Chrissovaladis Koumpis et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2011)
PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality
Elena Lopez-Knowles et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Breast cancer susceptibility: current knowledge and implications for genetic counselling
Tim Ripperger et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
James D. Fackenthal et al.
NATURE REVIEWS CANCER (2007)
BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients:: interactions with genetic, ethnic and reproductive factors
Khalid Dafaallah Awadelkarim et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years
Kathleen E. Malone et al.
CANCER RESEARCH (2006)
Mutational hotspot in Exon 20 of PIK3CA in breast cancer among Singapore Chinese
Xiaohui Liang et al.
CANCER BIOLOGY & THERAPY (2006)
Cancer-specific mutations in PIK3CA are oncogenic in vivo
AG Bader et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hereditary breast and ovarian cancer: review and future perspectives
MP Lux et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Cancer susceptibility and the functions of BRCA1 and BRCA2
AR Venkitaraman
CELL (2002)
Predicting deleterious amino acid substitutions
PC Ng et al.
GENOME RESEARCH (2001)
Share Paper
